Gilead’s Combination Hep C Drug Likely to Win Japan Approval Late June

May 29, 2015
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) Second Committee on Drugs on May 28 recommended approval of Gilead Sciences K.K.’s combination hepatitis C drug, paving the way for its Japanese approval as early as late June and NHI price...read more